Research and Markets: Anti-Adhesion Products – Global Strategic Business Report

This report analyzes the worldwide markets for Anti-Adhesion Products in US$ Million by the following three major End-Use Segments: General/Abdominal Surgery, Pelvic/Gynecological Surgery, and Other Surgical Procedures. The report provides separate comprehensive analytics for US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018.

The report profiles 25 companies including many key and niche players such as Angiotech Pharmaceuticals, Inc., Anika Therapeutics, Inc., Anika Therapeutics S.R.L., Baxter International, Inc., Ethicon, Inc., Genzyme Corporation, Covidien, FzioMed, Inc., Integra LifeSciences Corporation, LifeCell Corporation, MAST Biosurgery AG, and Pathfinder Cell Therapy, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

2. ADVANCED WOUND CARE TECHNOLOGIES – AN OVERVIEW OF THE LARGER MARKET

3. PRODUCT OVERVIEW

4. PRODUCT INTRODUCTIONS/APPROVALS

5. RECENT INDUSTRY ACTIVITY

6. CORPORATE ACTIVITY IN RECENT PAST – A PERSPECTIVE BUILDER

7. FOCUS ON SELECT GLOBAL PLAYERS

8. GLOBAL MARKET PERSPECTIVE

III. MARKET

1. THE UNITED STATES

2. EUROPE

2a. FRANCE

2b. GERMANY

2c. ITALY

2d. THE UNITED KINGDOM

2e. SPAIN

2f. REST OF EUROPE

3. REST OF WORLD

IV. COMPETITIVE LANDSCAPE

– Angiotech Pharmaceutic Inc.

– Anika Therapeutics Inc

– Baxter International Inc.

– Genzyme Corporation

– Covidien

– Ethicon

– Fidia Farmaceutici

– S.P.A

– FzioMed Inc.

– Integra LifeSciences Corporation

– LifeCell Corporation

– MAST Biosurgery AG

– Synthemed Inc